Triple

T1103709
Position Surface form Disambiguated ID Type / Status
Subject Leqembi E25439 entity
Predicate hasRegulatoryPathway P14058 FINISHED
Object FDA traditional approval
FDA traditional approval is the U.S. Food and Drug Administration’s standard, full marketing authorization pathway granted when a drug has demonstrated substantial evidence of safety and effectiveness through adequate and well-controlled studies.
E125382 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: FDA traditional approval | Statement: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: FDA traditional approval
Context triple: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
  • A. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. Federal Food, Drug, and Cosmetic Act
    The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: FDA traditional approval
Triple: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
Generated description
FDA traditional approval is the U.S. Food and Drug Administration’s standard, full marketing authorization pathway granted when a drug has demonstrated substantial evidence of safety and effectiveness through adequate and well-controlled studies.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: FDA traditional approval
Target entity description: FDA traditional approval is the U.S. Food and Drug Administration’s standard, full marketing authorization pathway granted when a drug has demonstrated substantial evidence of safety and effectiveness through adequate and well-controlled studies.
  • A. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. Federal Food, Drug, and Cosmetic Act
    The Federal Food, Drug, and Cosmetic Act is a key U.S. law that authorizes the Food and Drug Administration to regulate the safety, labeling, and marketing of food, drugs, medical devices, and cosmetics.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • E. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: hasRegulatoryPathway
Context triple: [Leqembi, hasRegulatoryPathway, FDA traditional approval]
  • A. regulatoryInteraction
    Indicates a relationship where one entity modulates, controls, or influences the activity, expression, or function of another entity through regulatory mechanisms.
  • B. regulatoryType chosen
    Indicates the specific kind or category of regulatory control, rule, or oversight that applies in the given relationship.
  • C. regulatoryOutcome
    Indicates the result or consequence of a regulatory process, such as approval, rejection, modification, or other formal decision made by a regulatory authority regarding an entity or action.
  • D. regulatesWith
    Indicates that one entity controls, modulates, or influences the activity, state, or behavior of another entity through some regulatory mechanism or interaction.
  • E. doesNotDirectlyRegulate
    Indicates that one entity has no immediate or primary regulatory control or influence over another entity or process.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a49428d4448190b3b36991ceae87ce completed March 1, 2026, 7:31 p.m.
NER Named-entity recognition batch_69a4b9c375848190baec4d534f489616 completed March 1, 2026, 10:12 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac4c4a402081908ee138257425a336 completed March 7, 2026, 4:03 p.m.
NEDg Description generation batch_69ac4ccf989c8190aed2ff01ad6fbcab completed March 7, 2026, 4:05 p.m.
NED2 Entity disambiguation (via description) batch_69ac4d4cbed88190ac743160198493b2 completed March 7, 2026, 4:07 p.m.
PD Predicate disambiguation batch_69a4b7472c848190b0643872f67084a2 completed March 1, 2026, 10:01 p.m.
Created at: March 1, 2026, 7:43 p.m.